ArticleJournal of neuroendocrinology2025

PRRT plus holmium-166-SIRT (HEPAR PLuS) versus PRRT-only in patients with metastatic neuroendocrine tumors: A propensity-score matched analysis.

W B Veldhuis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.